Literature DB >> 19584263

Elevated poly-(ADP-ribose)-polymerase activity sensitizes retinoblastoma-deficient cells to DNA damage-induced necrosis.

Huiping Liu1, James R Knabb, Benjamin T Spike, Kay F Macleod.   

Abstract

The retinoblastoma (Rb) tumor suppressor is a key regulator of cell cycle checkpoints but also protects against cell death induced by stresses such as DNA damage and death receptor ligation. We report here that cell death of Rb-deficient cells exposed to key genotoxic agents was associated with increased expression of S phase-specific E2F target genes and cell death consistently occurred in the S phase of the cell cycle. Cell cycle arrest induced by serum starvation prevented S phase entry, attenuated DNA damage, and promoted survival, suggesting that Rb-null cells die due to a failure to prevent S phase entry. DNA damage-induced death of Rb-null cells was associated with nucleotide depletion, higher activity of poly-ADP-ribose-polymerase (Parp), and cell death that was primarily necrotic. Knockdown of Parp-1 or chemical inhibition of Parp activity prevented nucleotide depletion and restored the viability of Rb-deficient cells to wild-type levels. Furthermore, chemical inhibition of Parp activity in vivo attenuated the cytotoxic effects of cisplatin against Rb-deficient tumors, arguing that Parp inhibitors should not be used therapeutically in combination with genotoxic drugs against tumors that are inactivated for the Rb tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584263      PMCID: PMC2994938          DOI: 10.1158/1541-7786.MCR-08-0439

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  28 in total

1.  Mitogen requirement for cell cycle progression in the absence of pocket protein activity.

Authors:  Floris Foijer; Rob M F Wolthuis; Valerie Doodeman; René H Medema; Hein te Riele
Journal:  Cancer Cell       Date:  2005-12       Impact factor: 31.743

2.  Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system.

Authors:  K F Macleod; Y Hu; T Jacks
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

Review 3.  mTOR and cancer: insights into a complex relationship.

Authors:  David M Sabatini
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

Review 4.  Poly(ADP-ribose): novel functions for an old molecule.

Authors:  Valérie Schreiber; Françoise Dantzer; Jean-Christophe Ame; Gilbert de Murcia
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

5.  Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts.

Authors:  R E Herrera; V P Sah; B O Williams; T P Mäkelä; R A Weinberg; T Jacks
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  E2F1 is crucial for E2F-dependent apoptosis.

Authors:  Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

7.  Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus.

Authors:  Dara Ditsworth; Wei-Xing Zong; Craig B Thompson
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

Review 8.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

9.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Authors:  Helen E Bryant; Niklas Schultz; Huw D Thomas; Kayan M Parker; Dan Flower; Elena Lopez; Suzanne Kyle; Mark Meuth; Nicola J Curtin; Thomas Helleday
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

View more
  12 in total

1.  Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion.

Authors:  Adam Pickard; Ann-Christin Cichon; Anna Barry; Declan Kieran; Daksha Patel; Peter Hamilton; Manuel Salto-Tellez; Jacqueline James; Dennis J McCance
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  Targeting the RB-pathway in cancer therapy.

Authors:  Erik S Knudsen; Jean Y J Wang
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

4.  Harnessing the cell death pathway for targeted cancer treatment.

Authors:  Christina K Speirs; Misun Hwang; Sungjune Kim; Weier Li; Sophia Chang; Vinod Varki; Lauren Mitchell; Stephen Schleicher; Bo Lu
Journal:  Am J Cancer Res       Date:  2010-09-30       Impact factor: 6.166

Review 5.  Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again?

Authors:  Lauren E Drake; Kay F Macleod
Journal:  J Pathol       Date:  2014-02       Impact factor: 7.996

6.  Loss of RBF1 changes glutamine catabolism.

Authors:  Brandon N Nicolay; Paulo A Gameiro; Katrin Tschöp; Michael Korenjak; Andreas M Heilmann; John M Asara; Gregory Stephanopoulos; Othon Iliopoulos; Nicholas J Dyson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

7.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

Review 8.  The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks.

Authors:  Máté A Demény; László Virág
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

9.  Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein.

Authors:  Adam Pickard; Ann-Christin Cichon; Craig Menges; Daksha Patel; Dennis J McCance
Journal:  J Invest Dermatol       Date:  2012-06-14       Impact factor: 8.551

10.  Construction of a computable network model for DNA damage, autophagy, cell death, and senescence.

Authors:  Stephan Gebel; Rosemarie B Lichtner; Brian Frushour; Walter K Schlage; Vy Hoang; Marja Talikka; Arnd Hengstermann; Carole Mathis; Emilija Veljkovic; Michael Peck; Manuel C Peitsch; Renee Deehan; Julia Hoeng; Jurjen W Westra
Journal:  Bioinform Biol Insights       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.